Nipocalimab — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12-15 in 1mo
ESTIMATED |
READOUT
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory De
Phase 2/3 · Polyradiculoneuropathy, Chronic Inflammatory Demyelinating |
Janssen Research & Development, LL | Nipocalimab |
ClinicalTrials.gov ↗
✓ Source-checked 2026-11-04
Sponsor-projected date — can change
|